Literature DB >> 2824806

Polymorphic proteins encoded within BZLF1 of defective and standard Epstein-Barr viruses disrupt latency.

J Countryman1, H Jenson, R Seibl, H Wolf, G Miller.   

Abstract

These experiments identify an Epstein-Barr virus-encoded gene product, called ZEBRA (BamHI fragment Z Epstein-Barr replication activator) protein, which activates a switch between the latent and replicative life cycle of the virus. Our previous work had shown that the 2.7-kilobase-pair WZhet piece of rearranged Epstein-Barr virus DNA from a defective virus activated replication when introduced into cells with a latent genome, but it was not clear whether a protein product was required for the phenomenon. We now use deletional, site-directed, and chimeric mutagenesis, together with gene transfer, to show that a 43-kilodalton protein, encoded in the BZLF1 open reading frame of het DNA, is responsible for this process. The rearrangement in defective DNA does not contribute to the structural gene for the protein. Similar proteins with variable electrophoretic mobility (37 to 39 kilodaltons) were encoded by BamHI Z fragments from standard, nondefective Epstein-Barr virus genomes. Plasmids expressing the ZEBRA proteins from B95-8 and HR-1 viruses were less efficient at activating replication in D98/HR-1 cells than those which contained the ZEBRA gene from the defective virus. It is not yet known whether these functional differences are due to variations in expression of the plasmids or to intrinsic differences in the activity of these polymorphic polypeptides.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2824806      PMCID: PMC255978          DOI: 10.1128/JVI.61.12.3672-3679.1987

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA.

Authors:  J Countryman; G Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

2.  A second nuclear protein is encoded by Epstein-Barr virus in latent infection.

Authors:  K Hennessy; E Kieff
Journal:  Science       Date:  1985-03-08       Impact factor: 47.728

3.  Constitutive expression of Epstein-Barr virus-encoded RNAs and nuclear antigen during latency and after induction of Epstein-Barr virus replication.

Authors:  R Weigel; D K Fischer; L Heston; G Miller
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

4.  trans activation of the latent Epstein-Barr virus (EBV) genome after transfection of the EBV DNA fragment.

Authors:  K Takada; N Shimizu; S Sakuma; Y Ono
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

5.  DNA sequence and expression of the B95-8 Epstein-Barr virus genome.

Authors:  R Baer; A T Bankier; M D Biggin; P L Deininger; P J Farrell; T J Gibson; G Hatfull; G S Hudson; S C Satchwell; C Séguin
Journal:  Nature       Date:  1984 Jul 19-25       Impact factor: 49.962

6.  Epstein-Barr virus with heterogeneous DNA disrupts latency.

Authors:  G Miller; M Rabson; L Heston
Journal:  J Virol       Date:  1984-04       Impact factor: 5.103

7.  High efficiency polyoma DNA transfection of chloroquine treated cells.

Authors:  H Luthman; G Magnusson
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

8.  A membrane protein encoded by Epstein-Barr virus in latent growth-transforming infection.

Authors:  K Hennessy; S Fennewald; M Hummel; T Cole; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

9.  A third viral nuclear protein in lymphoblasts immortalized by Epstein-Barr virus.

Authors:  K Hennessy; S Fennewald; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

10.  Spliced RNA from the IR1-U2 region of Epstein-Barr virus: presence of an open reading frame for a repetitive polypeptide.

Authors:  M Bodescot; B Chambraud; P Farrell; M Perricaudet
Journal:  EMBO J       Date:  1984-08       Impact factor: 11.598

View more
  133 in total

1.  Genetic dissection of cell growth arrest functions mediated by the Epstein-Barr virus lytic gene product, Zta.

Authors:  A Rodriguez; M Armstrong; D Dwyer; E Flemington
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

2.  Identification of a novel element involved in regulation of the lytic switch BZLF1 gene promoter of Epstein-Barr virus.

Authors:  R J Kraus; S J Mirocha; H M Stephany; J R Puchalski; J E Mertz
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

3.  Possible involvement of IL-12 expression by Epstein-Barr virus in Sjögren syndrome.

Authors:  M Horiuchi; S Yamano; H Inoue; J Ishii; Y Nagata; H Adachi; M Ono; J N Renard; F Mizuno; Y Hayashi; I Saito
Journal:  J Clin Pathol       Date:  1999-11       Impact factor: 3.411

4.  Murine gammaherpesvirus 68 cyclin D homologue is required for efficient reactivation from latency.

Authors:  A T Hoge; S B Hendrickson; W H Burns
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

Review 5.  Herpesvirus lytic replication and the cell cycle: arresting new developments.

Authors:  E K Flemington
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

6.  The K-bZIP protein from Kaposi's sarcoma-associated herpesvirus interacts with p53 and represses its transcriptional activity.

Authors:  J Park; T Seo; S Hwang; D Lee; Y Gwack; J Choe
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

7.  Rearranged Epstein-Barr virus genome in Hodgkin's disease and angioimmunoblastic lymphadenopathy: Swiss results.

Authors:  Hans Knecht; Bernhard F Odermatt
Journal:  Am J Pathol       Date:  2003-07       Impact factor: 4.307

8.  Marked variation in the size of genomic plasmids among members of a family of related Epstein-Barr viruses.

Authors:  J L Kolman; C J Kolman; G Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

9.  The Epstein-Barr virus R transactivator (Rta) contains a complex, potent activation domain with properties different from those of VP16.

Authors:  J M Hardwick; L Tse; N Applegren; J Nicholas; M A Veliuona
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

10.  Two phenylalanines in the C-terminus of Epstein-Barr virus Rta protein reciprocally modulate its DNA binding and transactivation function.

Authors:  Lee-Wen Chen; Vineetha Raghavan; Pey-Jium Chang; Duane Shedd; Lee Heston; Henri-Jacques Delecluse; George Miller
Journal:  Virology       Date:  2009-02-15       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.